Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant

John J. Millichap, Francesco Miceli, Michela De Maria, Cynthia Keator, Nishtha Joshi, Baouyen Tran, Maria Virginia Soldovieri, Paolo Ambrosino, Vandana Shashi, Mohamad A. Mikati, Edward C. Cooper*, Maurizio Taglialatela

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Abstract

Variants in KCNQ2 encoding for Kv7.2 neuronal K+ channel subunits lead to a spectrum of neonatal-onset epilepsies, ranging from self-limiting forms to severe epileptic encephalopathy. Most KCNQ2 pathogenic variants cause loss-of-function, whereas few increase channel activity (gain-of-function). We herein provide evidence for a new phenotypic and functional profile in KCNQ2-related epilepsy: infantile spasms without prior neonatal seizures associated with a gain-of-function gene variant. With use of an international registry, we identified four unrelated patients with the same de novo heterozygous KCNQ2 c.593G>A, p.Arg198Gln (R198Q) variant. All were born at term and discharged home without seizures or concern of encephalopathy, but developed infantile spasms with hypsarrhythmia (or modified hypsarrhythmia) between the ages of 4 and 6 months. At last follow-up (ages 3–11 years), all patients were seizure-free and had severe developmental delay. In vitro experiments showed that Kv7.2 R198Q subunits shifted current activation gating to hyperpolarized potentials, indicative of gain-of-function; in neurons, Kv7.2 and Kv7.2 R198Q subunits similarly populated the axon initial segment, suggesting that gating changes rather than altered subcellular distribution contribute to disease molecular pathogenesis. We conclude that KCNQ2 R198Q is a model for a new subclass of KCNQ2 variants causing infantile spasms and encephalopathy, without preceding neonatal seizures. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.

Original languageEnglish (US)
Pages (from-to)e10-e15
JournalEpilepsia
Volume58
Issue number1
DOIs
StatePublished - Jan 1 2017

Funding

The present study was supported by grants from the American Epilepsy Society/Epilepsy Foundation Research Infrastructure program. The Jack Pribaz Foundation, National Institutes of Health (NIH) NS49119 to ECC; the Telethon Foundation GGP15113 to MT; and a Ministry of Education, University and Research Scientific Independence for young Researchers (SIR) grant (SIR 2014 RBSI1444EM) to FM. We are deeply indebted to participating families and to the Jack Pribaz Foundation and the KCNQ2 Cure Alliance for referrals to the RIKEE Registry; Dr. Thomas J. Jentsch, Department of Physiology and Pathology of Ion Transport, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin (Germany), for sharing KCNQ2 and KCNQ3 cDNAs; Dr. David E. Shaw, D.E. Shaw Research, New York, NY (U.S.A.), for the coordinates of the Kv1.2/2.1 chimera; and Drs. Edoardo Moretto and Maria Passafaro, CNR Institute for Neuroscience, Milan (Italy), for help with setting up neuronal transfection and immunocytochemistry.

Keywords

  • Epileptic encephalopathy
  • Gene variants
  • Genotype–phenotype
  • KCNQ2
  • Potassium channels
  • axon initial segment
  • retigabine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint

Dive into the research topics of 'Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant'. Together they form a unique fingerprint.

Cite this